The Chemours Co (CC)
27.00
+0.85
(+3.25%)
USD |
NYSE |
May 03, 14:15
Chemours Enterprise Value: 7.159B for May 2, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 7.159B |
| May 01, 2024 | 7.136B |
| April 30, 2024 | 7.248B |
| April 29, 2024 | 7.388B |
| April 26, 2024 | 7.333B |
| April 25, 2024 | 7.289B |
| April 24, 2024 | 7.297B |
| April 23, 2024 | 7.245B |
| April 22, 2024 | 7.200B |
| April 19, 2024 | 7.123B |
| April 18, 2024 | 7.207B |
| April 17, 2024 | 7.191B |
| April 16, 2024 | 7.197B |
| April 15, 2024 | 7.139B |
| April 12, 2024 | 7.207B |
| April 11, 2024 | 7.329B |
| April 10, 2024 | 7.361B |
| April 09, 2024 | 7.457B |
| April 08, 2024 | 7.292B |
| April 05, 2024 | 7.288B |
| April 04, 2024 | 7.328B |
| April 03, 2024 | 7.542B |
| April 02, 2024 | 7.374B |
| April 01, 2024 | 7.541B |
| March 31, 2024 | 7.172B |
| Date | Value |
|---|---|
| March 28, 2024 | 6.745B |
| March 27, 2024 | 7.134B |
| March 26, 2024 | 6.910B |
| March 25, 2024 | 7.059B |
| March 22, 2024 | 6.983B |
| March 21, 2024 | 6.887B |
| March 20, 2024 | 6.892B |
| March 19, 2024 | 6.916B |
| March 18, 2024 | 6.968B |
| March 15, 2024 | 6.870B |
| March 14, 2024 | 6.797B |
| March 13, 2024 | 6.825B |
| March 12, 2024 | 6.715B |
| March 11, 2024 | 6.718B |
| March 08, 2024 | 6.676B |
| March 07, 2024 | 6.605B |
| March 06, 2024 | 6.110B |
| March 05, 2024 | 5.885B |
| March 04, 2024 | 5.837B |
| March 01, 2024 | 5.925B |
| February 29, 2024 | 5.760B |
| February 28, 2024 | 7.104B |
| February 27, 2024 | 7.136B |
| February 26, 2024 | 7.127B |
| February 23, 2024 | 7.217B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
4.518B
Minimum
Apr 03 2020
9.535B
Maximum
Jun 07 2022
7.159B
Average
7.238B
Median
Enterprise Value Benchmarks
| Albemarle Corp | 18.70B |
| Olin Corp | 9.014B |
| 5E Advanced Materials Inc | 136.33M |
| Balchem Corp | 4.965B |
| Innospec Inc | 2.825B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 52.00M |
| Revenue (Quarterly) | 1.35B |
| Total Expenses (Quarterly) | 1.24B |
| EPS Diluted (Quarterly) | 0.34 |
| Gross Profit Margin (Quarterly) | 21.19% |
| Profit Margin (Quarterly) | 3.85% |
| Earnings Yield | -8.26% |
| Normalized Earnings Yield | -7.690 |